Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

Poxel reports PK/PD study data on PXL-770 in likely NASH patients with insulin resistance

June 25, 2020

Microbiome-produced metabolites improve gut health

June 23, 2020

FDA approves Gimoti for acute and recurrent diabetic gastroparesis

June 22, 2020

FXR agonist TERN-101 enters phase IIa study for NASH

June 19, 2020

New peripheral 5-HT2A antagonists for NAFLD treatment by structural modification of pimavanserin

June 19, 2020

Positive data presented from FASCINATE-1 phase II study of ASC-40

June 18, 2020

Phase IIb study of lanifibranor in NASH meets primary and key secondary endpoints

June 16, 2020

CytoDyn initiates phase II study of leronlimab for NASH

June 12, 2020

Bacainn announces phase I study initiation for ulcerative colitis candidate BT-051

June 10, 2020

Positive topline data presented from two phase I studies of VE-202

June 9, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 20, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
Anle-138b reduces mHTT aggregation, improves pathological phenotypes in Huntington’s models
BioWorld Science
Anle-138b (emrusolmin) is a diphenylpyrazole compound that directly interacts with oligomeric species of disease-related aggregating proteins, reducing aggregate...